Conversely, lower serum levels of IFNg in HCC patients are associated with advanced tumor stage and worse prognosis, so monitoring for increases in serum IFNg is a potential modality for determining cold to hot HCC conversion, but this needs to be validated for standard clinical use [165]. Here, IFNG is linked to hepatocellular carcinoma.